Link Pharma Chem Limited (BOM:524748)

Link Pharma Chem Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	-	5.88	0.65	0.64	0.94	2.68
Cash & Short-Term Investments	5.88	5.88	0.65	0.64	0.94	2.68
Cash Growth	811.01%	811.01%	0.47%	-31.63%	-64.95%	-94.48%
Accounts Receivable	-	52.8	50.17	51.52	36.3	53.65
Other Receivables	-	-	-	-	0.18	0.53
Receivables	-	53	50.26	51.64	37.2	54.59
Inventory	-	50.23	57.37	62.08	122.5	47.57
Prepaid Expenses	-	0.68	0.64	0.64	0.47	0.72
Other Current Assets	-	3.62	2.68	0.26	14.39	30.15
Total Current Assets	-	113.4	111.59	115.26	175.49	135.72
Property, Plant & Equipment	-	103.77	92.77	99.37	90.03	89.97
Long-Term Investments	-	24.73	20.55	29.33	36.39	45.19
Long-Term Deferred Tax Assets	-	1.57	2.32	-	-	-
Other Long-Term Assets	-	6.14	5.69	15.54	22.67	18.77
Total Assets	-	249.62	232.93	259.5	324.58	289.64

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	-	32.55	34.83	17.58	66.07	45.28
Accrued Expenses	-	13.15	11.59	10.64	9.24	23.91
Short-Term Debt	-	62.66	51.23	78.18	57.89	25.84
Current Portion of Long-Term Debt	-	3.43	2.42	3.46	9.88	9.02
Current Income Taxes Payable	-	-	-	-	1.45	1.37
Other Current Liabilities	-	0.63	0.46	0.19	0.62	0.71
Total Current Liabilities	-	112.42	100.52	110.05	145.15	106.13
Long-Term Debt	-	6.95	4.17	10.58	19.8	29.02
Pension & Post-Retirement Benefits	-	2.36	1.62	0.02	2.02	0.35
Long-Term Deferred Tax Liabilities	-	-	-	1.76	7.23	9.41
Other Long-Term Liabilities	-	-	-	-	-0	-
Total Liabilities	-	121.73	106.31	122.42	174.19	144.89

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	-	44.41	44.41	44.41	44.41	44.41
Additional Paid-In Capital	-	28.71	28.71	28.71	28.71	28.71
Retained Earnings	-	54.66	53.39	63.85	77.19	71.54
Comprehensive Income & Other	-	0.12	0.11	0.12	0.09	0.09
Shareholders' Equity	127.89	127.89	126.62	137.09	150.39	144.75
Total Liabilities & Equity	-	249.62	232.93	259.5	324.58	289.64

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	73.04	73.04	57.82	92.22	87.57	63.88
Net Cash (Debt)	-67.17	-67.17	-57.18	-91.58	-86.63	-61.2
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-15.12	-15.13	-12.88	-20.62	-19.51	-13.78
Filing Date Shares Outstanding	4.42	4.44	4.44	4.44	4.44	4.44
Total Common Shares Outstanding	4.42	4.44	4.44	4.44	4.44	4.44
Working Capital	-	0.99	11.07	5.21	30.35	29.59
Book Value Per Share	28.80	28.80	28.51	30.87	33.87	32.60
Tangible Book Value	127.89	127.89	126.62	137.09	150.39	144.75
Tangible Book Value Per Share	28.80	28.80	28.51	30.87	33.87	32.60
Land	-	16.15	16.15	16.15	2.27	2.27
Buildings	-	28.34	25.84	25.84	26.32	19.57
Machinery	-	135.57	117.49	114.66	110.2	105.54
Construction In Progress	-	-	-	-	-	2.11

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 21, 2026

Data Sources Report a data error